CDC42BPA and breast carcinoma: Together, these findings suggest that the focal adhesion > MRCK > YAP/TAZ signaling loop plays an important role in TNBC, especially in the Claudin-low subtype, and MRCKi may be particularly effective drugs against the Claudin-low subtype breast cancer.